How short-term and long-term opioid use affects eye immune defenses and eye infections
Differential impact of acute and chronic opioids on ocular innate immunity and infections
This project looks at whether one-time versus repeated opioid use changes eye immune protection and the risk of eye infections for people who use opioids or have related infections like HIV.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Wayne State University NIH-funded |
| Lab location | 1 site (Detroit, United States) |
| Project ID | NIH-11264816 on NIH RePORTER |
What this research studies
From a patient's point of view, researchers will use lab-grown human retinal cells, immune cells from people, and mouse models to compare the effects of short-term (acute) and repeated (chronic) opioid exposure on eye inflammation and infection. They will measure immune signaling molecules (cytokines) in blood and retina and check for pathogens such as Candida and Staphylococcus in eye tissue. The team builds on early results showing single opioid exposure increased inflammation in cells, while repeated exposure lowered blood cytokines but raised retinal cytokines and increased fungal burden in mice. The goal is to explain why opioid use has been linked to more eye infections and to point toward prevention or treatment options.
Who could benefit from this research
Good fit: People who use opioids — especially those with opioid use disorder, HIV infection, or a history of endogenous endophthalmitis or recurrent fungal/bacterial eye infections — would be most relevant to this research.
Not a fit: People without opioid exposure or without risk factors for infectious eye disease would be unlikely to receive direct benefit from this work.
Why it matters
Potential benefit: If successful, this work could help prevent or better treat opioid-associated eye infections by clarifying when and how opioids weaken eye immune defenses.
How similar studies have performed: Previous clinical and animal studies suggest opioids alter immune responses and raise infection risk, but directly comparing acute versus chronic opioid effects on eye immunity is largely novel.
Where this research is happening
Detroit, United States
- Wayne State University — Detroit, United States (Active)
Researchers
- Principal investigator: Kumar, Ashok — Wayne State University
- Study coordinator: Kumar, Ashok
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.